SNW:ETR
Sanofi
74,79 €
arrow_downward
-1,15%(-0,87) 1 d
8 sept, 17:35:40 GMT+2 · EUR
search
Todos los símbolos
1 d
5 d
1 m
6 m
YTD
1 a
5 a
MÁX.
| Símbolo | Precio | Cambio | % de cambio |
|---|
insights_autoGenerando estadísticas principales de SNW...
Abrir
75,86 €
Alto
75,93 €
Bajo
74,39 €
Cap. burs.
90,24 mil M
Vol. medio
15,75 mil
Volumen
12,32 mil
Ratio PER
22,94
Máximo en 52 sem.
90,75 €
Mínimo en 52 sem.
71,25 €
BPA
3,26 €
Acciones en circulación
1254,02 M
N.º de empleados
75 mil
Abrir
75,86 €
Alto
75,93 €
Bajo
74,39 €
Cap. burs.
90,24 mil M
Vol. medio
15,75 mil
Volumen
12,32 mil
Ratio PER
22,94
Máximo en 52 sem.
90,75 €
Mínimo en 52 sem.
71,25 €
BPA
3,26 €
Acciones en circulación
1254,02 M
N.º de empleados
75 mil
Noticias
De fuentes web y partners de noticias
AD HOC NEWS
·
hace 2 horas
Sanofi stock steadies as EU clears EUR 400 million insulin aid and Barclays lifts target
Yahoo Finance
·
hace 5 horas
EU greenlights €400 million in aid for Sanofi insulin plant in Germany
Stock Titan
·
hace 6 horas
Keke Palmer’s baby received medicine to help prevent serious lung illness. She joins Sanofi’s parent campaign.
CNBC TV18
·
hace 7 horas
Sanofi India's petition to quash criminal proceedings dismissed by Supreme Court
Perfil
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company was ranked 89th in the Forbes Global 2000.
Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. It is one of the world's largest producer of vaccines through its subsidiary Sanofi Pasteur. Wikipedia
Acerca de Sanofi
CEOPaul Hudson | Belén Garijo
Empleados74,8 mil
Fundación1973
SedeParís, Isla de Francia, Francia
Sector-
Sitio websanofi.com